TELIX Pharmaceuticals Ltd (TLX) — Financial Flexibility Index
TELIX Pharmaceuticals Ltd (TLX) has a Financial Flexibility Index of 0.05x as of June 2025. Free cash flow of AU$38.11 Million (operating CF AU$27.98 Million minus capex AU$10.13 Million) represents 0% of total liabilities (AU$768.01 Million). Also explore net asset growth rate of TELIX Pharmaceuticals Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TELIX Pharmaceuticals Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for TELIX Pharmaceuticals Ltd across 8 annual periods. Check strategic asset allocation of TELIX Pharmaceuticals Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for TELIX Pharmaceuticals Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for TELIX Pharmaceuticals Ltd. For the full company profile including market capitalisation, see TELIX Pharmaceuticals Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | AU$77.06 Million | AU$43.03 Million | AU$948.22 Million | ▼ -41.6% |
| 2023 | 0.14x | AU$34.68 Million | AU$23.88 Million | AU$249.39 Million | ▲ +149.5% |
| 2022 | -0.28x | AU$-50.11 Million | AU$-63.97 Million | AU$178.44 Million | ▲ +48.6% |
| 2021 | -0.55x | AU$-57.99 Million | AU$-59.33 Million | AU$106.17 Million | ▼ -1986.2% |
| 2020 | 0.03x | AU$2.28 Million | AU$1.96 Million | AU$78.81 Million | ▲ +104.0% |
| 2019 | -0.72x | AU$-22.86 Million | AU$-23.33 Million | AU$31.88 Million | ▲ +16.1% |
| 2018 | -0.85x | AU$-20.34 Million | AU$-20.75 Million | AU$23.80 Million | ▲ +74.5% |
| 2017 | -3.35x | AU$-6.03 Million | AU$-6.03 Million | AU$1.80 Million | — |